scholarly journals Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions

2021 ◽  
Vol 62 (6) ◽  
pp. 21
Author(s):  
Yao-Tseng Wen ◽  
Ching-Wen Huang ◽  
Chih-Peng Liu ◽  
Chih-Hung Chen ◽  
Chia-Mu Tu ◽  
...  
2021 ◽  
Vol Volume 14 ◽  
pp. 6857-6869
Author(s):  
Qianxue Mou ◽  
Ke Yao ◽  
Meng Ye ◽  
Bowen Zhao ◽  
Yuanyuan Hu ◽  
...  

Development ◽  
2021 ◽  
Author(s):  
Si Chen ◽  
Kira L. Lathrop ◽  
Takaaki Kuwajima ◽  
Jeffrey M. Gross

Visual information is transmitted from the eye to the brain along the optic nerve, a structure composed of retinal ganglion cell (RGC) axons. The optic nerve is highly vulnerable to damage in neurodegenerative diseases like glaucoma and there are currently no FDA-approved drugs or therapies to protect RGCs from death. Zebrafish possess remarkable neuroprotective and regenerative abilities and here, utilizing an optic nerve transection (ONT) injury and an RNA-seq-based approach, we identify genes and pathways active in RGCs that may modulate their survival. Through pharmacological perturbation, we demonstrate that JAK/STAT pathway activity is required for RGC survival after ONT. Furthermore, we show that immune responses directly contribute to RGC death after ONT; macrophages/microglia are recruited to the retina and blocking neuroinflammation or depleting these cells after ONT rescues survival of RGCs. Taken together, these data support a model in which crosstalk between macrophages/microglia and RGCs, mediated by Jak/Stat pathway activity, regulates RGC survival after optic nerve injury.


2020 ◽  
Vol 200 ◽  
pp. 108240
Author(s):  
Yuan-Yuan He ◽  
Lu Wang ◽  
Tao Zhang ◽  
Shi-Jun Weng ◽  
Jian Lu ◽  
...  

2021 ◽  
Vol 62 (9) ◽  
pp. 5
Author(s):  
Delaney C. M. Henderson ◽  
Jayme R. Vianna ◽  
John Gobran ◽  
Johnny Di Pierdomenico ◽  
Michele L. Hooper ◽  
...  

2020 ◽  
Vol 18 (9) ◽  
pp. 695-704 ◽  
Author(s):  
Bei Liu ◽  
Yu-Jia Liu

Background: Carvedilol, which is considered as a nonselective β-adrenoreceptor blocker, has many pleiotropic activities. It also causes great impact on neuroprotection because of its antioxidant ability, which suggested that carvedilol may be effective in protecting RGCs from increased oxidative stress. Objective: To examine the effects of carvedilol on preventing Retinal Ganglion Cell (RGC) death in a mouse model of Optic Nerve Injury (ONI). Methods: C57BL/6J mice were subjected to Optic Nerve Injury (ONI) model and treated with carvedilol or placebo. Histological and morphometric studies were performed; the RGC number, the amount of neurons in the ganglion cell layer and the thickness of the Inner Retinal Layer (IRL) was quantified. The average thickness of Ganglion Cell Complex (GCC) was determined by the Spectral- Domain OCT (SD-OCT) assay. Immunohistochemistry, western blot and quantitative real-time PCR analysis were also applied. Results: Daily treatment of carvedilol reduced RGC death following ONI, and in vivo retinal imaging revealed that carvedilol can effectively prevent retinal degeneration. The expression of chemokines important for micorglia recruitment was deceased with carvedilol ingestion and the accumulation of retinal microglia is reduced consequently. In addition, the ONI-induced expression of inducible nitric oxide synthase in the retina was inhibited with carvedilol treatment in the retina. We also discovered that carvedilol suppressed ONI-induced activation of Apoptosis Signal-regulating Kinase-1 (ASK1) and p38 Mitogen-Activated Protein Kinase (MAPK) pathway. Conclusion: The results of this study indicate that carvedilol can stimulate neuroprotection and neuroregeneration, and may be useful for treatment of various neurodegenerative diseases.


1999 ◽  
Vol 16 (2) ◽  
pp. 153-163 ◽  
Author(s):  
ANNETT BIEN ◽  
CONSTANZE I. SEIDENBECHER ◽  
TOBIAS M. BÖCKERS ◽  
BERNHARD A. SABEL ◽  
MICHAEL R. KREUTZ

Sign in / Sign up

Export Citation Format

Share Document